Whitehawk Therapeutics (WHWK) Revenue (QoQ) (2018 - 2025)
Whitehawk Therapeutics (WHWK) Revenue (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1.30% |
| Dec 31, 2024 | 0.37% |
| Sep 30, 2024 | 16.72% |
| Jun 30, 2024 | 15.43% |
| Mar 31, 2024 | -15.38% |
| Dec 31, 2023 | 6.16% |
| Sep 30, 2023 | -3.92% |
| Jun 30, 2023 | 5.71% |
| Mar 31, 2023 | 12.24% |
| Dec 31, 2022 | 23.13% |
| Sep 30, 2022 | 23.51% |
| Jun 30, 2022 | 48.98% |
| Mar 31, 2022 | -83.52% |
| Mar 31, 2021 | -99.14% |
| Dec 31, 2020 | 5,960.61% |
| Sep 30, 2020 | -98.46% |
| Dec 31, 2018 | -99.99% |
| Sep 30, 2018 | 1,311.65% |